FT
DGX icon

Fiduciary Trust’s Quest Diagnostics DGX Stock Holding History

Fiduciary Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$831K Sell
4,239
-114
-3% -$22.1K 0.01% 448
2025
Q4 		$755K Sell
4,353
-263
-6% -$47.9K 0.01% 475
2025
Q3 		$880K Sell
4,616
-109
-2% -$19.3K 0.01% 437
2025
Q2 		$849K Sell
4,725
-223
-5% -$38.7K 0.01% 433
2025
Q1 		$837K Buy
4,948
+488
+11% +$80.2K 0.01% 420
2024
Q4 		$673K Hold
4,460
– – 0.01% 433
2024
Q3 		$692K Buy
4,460
+60
+1% +$8.96K 0.01% 430
2024
Q2 		$602K Sell
4,400
-250
-5% -$34.2K 0.01% 423
2024
Q1 		$619K Sell
4,650
-190
-4% -$24.7K 0.01% 419
2023
Q4 		$667K Buy
4,840
+2
+0% +$263 0.01% 395
2023
Q3 		$590K Sell
4,838
-266
-5% -$35.4K 0.01% 407
2023
Q2 		$717K Buy
5,104
+6
+0.1% +$827 0.01% 379
2023
Q1 		$721K Hold
5,098
– – 0.01% 383
2022
Q4 		$798K Buy
5,098
+471
+10% +$67.7K 0.02% 378
2022
Q3 		$567K Buy
4,627
+400
+9% +$52.7K 0.01% 418
2022
Q2 		$562K Sell
4,227
-1
-0% -$136 0.01% 431
2022
Q1 		$579K Sell
4,228
-1
-0% -$139 0.01% 449
2021
Q4 		$731K Hold
4,229
– – 0.01% 404
2021
Q3 		$614K Sell
4,229
-166
-4% -$24.3K 0.01% 429
2021
Q2 		$580K Buy
4,395
+500
+13% +$65.5K 0.01% 437
2021
Q1 		$499K Hold
3,895
– – 0.01% 451
2020
Q4 		$464K Hold
3,895
– – 0.01% 443
2020
Q3 		$446K Sell
3,895
-15
-0.4% -$1.77K 0.01% 416
2020
Q2 		$446K Buy
3,910
+46
+1% +$4.88K 0.01% 397
2020
Q1 		$310K Buy
3,864
+9
+0.2% +$932 0.01% 414
2019
Q4 		$412K Sell
3,855
-2
-0.1% -$209 0.01% 409
2019
Q3 		$413K Sell
3,857
-200
-5% -$20.5K 0.01% 403
2019
Q2 		$413K Buy
4,057
+400
+11% +$38.4K 0.01% 377
2019
Q1 		$329K Sell
3,657
-3
-0.1% -$260 0.01% 396
2018
Q4 		$305K Sell
3,660
-13
-0.4% -$1.22K 0.01% 378
2018
Q3 		$397K Hold
3,673
– – 0.01% 363
2018
Q2 		$404K Sell
3,673
-200
-5% -$20.8K 0.01% 349
2018
Q1 		$388K Buy
3,873
+1,213
+46% +$124K 0.01% 356
2017
Q4 		$262K Hold
2,660
– – 0.01% 386
2017
Q3 		$249K Hold
2,660
– – 0.01% 396
2017
Q2 		$295K Hold
2,660
– – 0.01% 383
2017
Q1 		$261K Hold
2,660
– – 0.01% 400
2016
Q4 		$245K Hold
2,660
– – 0.01% 411
2016
Q3 		$225K Hold
2,660
– – 0.01% 418
2016
Q2 		$217K Sell
2,660
-220
-8% -$16.8K 0.01% 406
2016
Q1 		$206K Buy
2,880
+5
+0.2% +$335 0.01% 410
2015
Q4 		$205K Buy
+2,875
New +$193K 0.01% 370
2015
Q3 		– Sell
-2,960
Closed -$215K – 374
2015
Q2 		$215K Sell
2,960
-80
-3% -$5.91K 0.01% 338
2015
Q1 		$234K Hold
3,040
– – 0.01% 322
2014
Q4 		$204K Buy
+3,040
New +$192K 0.01% 335

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Fiduciary Trust's DGX Position: Q1 2026 in Review

Fiduciary Trust reduced its Quest Diagnostics (DGX) stake by 2.6% in Q1 2026, selling an estimated $22.1K and leaving 4,239 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #448.

Fiduciary Trust first reported a position in DGX in Q4 2014 and has held it in 45 quarters since. The position peaked at $880K in Q3 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Fiduciary Trust held 4,239 shares of Quest Diagnostics worth $831K as of Q1 2026.
  • Fiduciary Trust sold 114 Quest Diagnostics shares in Q1 2026, an estimated $22.1K.
  • Quest Diagnostics made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #448 holding.
  • Fiduciary Trust first reported a position in Quest Diagnostics in Q4 2014 and has held it in 45 quarters since.
  • Fiduciary Trust's Quest Diagnostics position peaked at $880K in Q3 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.